(Q80103226)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15150524%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

review article

1 reference

title

[How to treat and to prevent spontaneous bacterial peritonitis?] (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15150524%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

author name string

Jean-Didier Grangé

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15150524%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

publication date

1 April 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15150524%20AND%20SRC:MED&resulttype=core&format=json

Gastroenterologie Clinique et Biologique

28 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15150524%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

volume

28 Spec No 2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15150524%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

page(s)

B278-86

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15150524%20AND%20SRC:MED&resulttype=core&format=json

A prospective study of bacterial infections in patients with cirrhosis

28 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2995267-0

7 January 2021

Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. International Ascites Club

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2995267-0

7 January 2021

Translocation of gut bacteria in rats with cirrhosis to mesenteric lymph nodes partially explains the pathogenesis of spontaneous bacterial peritonitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2995267-0

7 January 2021

Effects of oral ciprofloxacin on aerobic gram-negative fecal flora in patients with cirrhosis: results of short- and long-term administration, with daily and weekly dosages

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2995267-0

7 January 2021

Risk of a first community-acquired spontaneous bacterial peritonitis in cirrhotics with low ascitic fluid protein levels

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2995267-0

7 January 2021

Amoxicillin-clavulanic acid versus cefotaxime in the therapy of bacterial infections in cirrhotic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2995267-0

7 January 2021

Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2995267-0

7 January 2021

Nosocomial and community-acquired spontaneous bacterial peritonitis: comparative microbiology and therapeutic implications

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2995267-0

7 January 2021

Nosocomial spontaneous bacterial peritonitis and bacteremia in cirrhotic patients: impact of isolate type on prognosis and characteristics of infection

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2995267-0

7 January 2021

Ascitic fluid analysis in the differentiation of spontaneous bacterial peritonitis from gastrointestinal tract perforation into ascitic fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2995267-0

7 January 2021

Prevalence and risk factors of bacteriuria in cirrhotic patients: a prospective case-control multicenter study in 244 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2995267-0

7 January 2021

Tumor necrosis factor and interleukin-6 in spontaneous bacterial peritonitis in cirrhosis: Relationship with the development of renal impairment and mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2995267-0

7 January 2021

Incidence and predictive factors of first episode of spontaneous bacterial peritonitis in cirrhosis with ascites: Relevance of ascitic fluid protein concentration

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2995267-0

7 January 2021

Risk factors for spontaneous bacterial peritonitis in cirrhotic patients with ascites

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2995267-0

7 January 2021

Recurrence of spontaneous bacterial peritonitis in cirrhosis: frequency and predictive factors

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2995267-0

7 January 2021

Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: results of a double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2995267-0

7 January 2021

Prognosis and long-term recurrence of spontaneous bacterial peritonitis in cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2995267-0

7 January 2021

Oral, nonabsorbable antibiotics prevent infection in cirrhotics with gastrointestinal hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2995267-0

7 January 2021

Frequency of infections in cirrhotic patients presenting with acute gastrointestinal haemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2995267-0

7 January 2021

Norfloxacin prevents bacterial infection in cirrhotics with gastrointestinal hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2995267-0

7 January 2021

The effect of ciprofloxacin in the prevention of bacterial infection in patients with cirrhosis after upper gastrointestinal bleeding

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2995267-0

7 January 2021

A comparison of the incidence of transient bacteremia and infectious sequelae after sclerotherapy and rubber band ligation of bleeding esophageal varices

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2995267-0

7 January 2021

Bacterial infection is independently associated with failure to control bleeding in cirrhotic patients with gastrointestinal hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2995267-0

7 January 2021

Presence of bacterial infection in bleeding cirrhotic patients is independently associated with early mortality and failure to control bleeding

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2995267-0

7 January 2021

Spontaneous bacterial peritonitis

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2995267-0

7 January 2021

The diagnosis of bacterial peritonitis: comparison of pH, lactate concentration and leukocyte count

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2995267-0

7 January 2021

Validation of automated blood cell counter for the determination of polymorphonuclear cell count in the ascitic fluid of cirrhotic patients with or without spontaneous bacterial peritonitis

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2995267-0

7 January 2021

Diagnostic accuracy of a rapid urine-screening test (Multistix8SG) in cirrhotic patients with spontaneous bacterial peritonitis

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2995267-0

7 January 2021

Rapid diagnosis of spontaneous bacterial peritonitis by use of reagent strips

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2995267-0

7 January 2021

Unsuspected infection is infrequent in asymptomatic outpatients with refractory ascites undergoing therapeutic paracentesis

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2995267-0

7 January 2021

Spontaneous bacterial peritonitis in asymptomatic outpatients with cirrhotic ascites

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2995267-0

7 January 2021

Monomicrobial nonneutrocytic bacterascites: a variant of spontaneous bacterial peritonitis

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2995267-0

7 January 2021

Asymptomatic bacterascites: is it spontaneous bacterial peritonitis?

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2995267-0

7 January 2021

Cefotaxime is more effective than is ampicillin-tobramycin in cirrhotics with severe infections

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2995267-0

7 January 2021

Amoxicillin-clavulanic acid therapy of spontaneous bacterial peritonitis: a prospective study of twenty-seven cases in cirrhotic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2995267-0

7 January 2021

Two different dosages of cefotaxime in the treatment of spontaneous bacterial peritonitis in cirrhosis: results of a prospective, randomized, multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2995267-0

7 January 2021

Randomized, comparative study of oral ofloxacin versus intravenous cefotaxime in spontaneous bacterial peritonitis

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2995267-0

7 January 2021

Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2995267-0

7 January 2021

Oral ciprofloxacin after a short course of intravenous ciprofloxacin in the treatment of spontaneous bacterial peritonitis: results of a multicenter, randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2995267-0

7 January 2021

Aztreonam vs. cefotaxime in the treatment of gram-negative spontaneous peritonitis in cirrhotic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2995267-0

7 January 2021

Short-course versus long-course antibiotic treatment of spontaneous bacterial peritonitis. A randomized controlled study of 100 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2995267-0

7 January 2021

Randomized trial comparing ceftriaxone with cefonicid for treatment of spontaneous bacterial peritonitis in cirrhotic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2995267-0

7 January 2021

Use of ceftriaxone in the treatment of bacterial infections in cirrhotic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2995267-0

7 January 2021

A prospective randomized trial of ceftazidime versus netilmicin plus mezlocillin in the empirical therapy of presumed sepsis in cirrhotic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2995267-0

7 January 2021

Short-course ceftriaxone therapy in spontaneous bacterial peritonitis

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2995267-0

7 January 2021

Polymorphonuclear cell count response and duration of antibiotic therapy in spontaneous bacterial peritonitis

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2995267-0

7 January 2021

Epidemiology of severe hospital-acquired infections in patients with liver cirrhosis: effect of long-term administration of norfloxacin

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2995267-0

7 January 2021

Development of quinolone-resistant strains of Escherichia coli in stools of patients with cirrhosis undergoing norfloxacin prophylaxis: clinical consequences

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2995267-0

7 January 2021

Spontaneous bacterial peritonitis in patients with cirrhosis undergoing selective intestinal decontamination

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2995267-0

7 January 2021

Prevalence and prognostic significance of bacterascites in cirrhosis with ascites

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2995267-0

7 January 2021

Prevalence and prognostic value of hepatocellular carcinoma in cirrhotic patients presenting with spontaneous bacterial peritonitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2995267-0

7 January 2021

Renal impairment after spontaneous bacterial peritonitis in cirrhosis: Incidence, clinical course, predictive factors and prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2995267-0

7 January 2021

Risk factors for the development of renal dysfunction in hospitalized patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2995267-0

7 January 2021

Management of adult patients with ascites caused by cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2995267-0

7 January 2021

Changing epidemiology and predictors of mortality in patients with spontaneous bacterial peritonitis at a liver transplant unit.

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2995267-0

7 January 2021

Selective intestinal decontamination prevents spontaneous bacterial peritonitis

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2995267-0

7 January 2021

Trimethoprim-sulfamethoxazole for the prevention of spontaneous bacterial peritonitis in cirrhosis: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2995267-0

7 January 2021

Continuous versus inpatient prophylaxis of the first episode of spontaneous bacterial peritonitis with norfloxacin.

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2995267-0

7 January 2021

Norfloxacin primary prophylaxis of bacterial infections in cirrhotic patients with ascites: a double-blind randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2995267-0

7 January 2021

Infectious sequelae after endoscopic sclerotherapy of oesophageal varices: role of antibiotic prophylaxis

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2995267-0

7 January 2021

Bacteremia and bacterascites after endoscopic sclerotherapy for bleeding esophageal varices and prevention by intravenous cefotaxime: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2995267-0

7 January 2021

Parenteral antibiotic prophylaxis of bacterial infections does not improve cost-efficacy of oral norfloxacin in cirrhotic patients with gastrointestinal bleeding

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2995267-0

7 January 2021

Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2995267-0

7 January 2021

Antibiotic Prophylaxis for the Prevention of Bacterial Infections in Cirrhotic Patients with Ascites: A Meta-Analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2995267-0

7 January 2021

An economic analysis of norfloxacin prophylaxis against spontaneous bacterial peritonitis

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2995267-0

7 January 2021

Cost-analysis of prophylactic antibiotics in spontaneous bacterial peritonitis

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2995267-0

7 January 2021

A cost analysis of long term antibiotic prophylaxis for spontaneous bacterial peritonitis in cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2995267-0

7 January 2021

Infections caused by Escherichia coli resistant to norfloxacin in hospitalized cirrhotic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2995267-0

7 January 2021

Changes in nature and antibiotic resistance of bacteria causing peritonitis in cirrhotic patients over a 20 year period

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2995267-0

7 January 2021

Trends in bacterial resistance to fluoroquinolones

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2995267-0

7 January 2021

Sequential mutations of gyrA in Escherichia coli associated with quinolone therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2995267-0

7 January 2021

Spontaneous bacterial peritonitis caused by quinolone-resistant Escherichia coli: could steroid therapy play a role?

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2995267-0

7 January 2021

Role of immunosuppression in the development of quinolone-resistant Escherichia coli spontaneous bacterial peritonitis and in the mortality of E. coli spontaneous bacterial peritonitis

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2995267-0

7 January 2021

Epidemiology of hospital-acquired infections in cirrhotic patients: effect of carriage of methicillin-resistant Staphylococcus aureus and influence of previous antibiotic therapy and norfloxacin prophylaxis

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2995267-0

7 January 2021

Small intestine dysmotility and bacterial overgrowth in cirrhotic patients with spontaneous bacterial peritonitis

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2995267-0

7 January 2021

Effect of cisapride on intestinal bacterial overgrowth and bacterial translocation in cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2995267-0

7 January 2021

Survival after a first episode of spontaneous bacterial peritonitis. Prognosis of potential candidates for orthotopic liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2995267-0

7 January 2021

Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2995267-0

7 January 2021

Successful treatment of fibrosing cholestatic hepatitis using adefovir dipivoxil in a patient with cirrhosis and renal insufficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2995267-0

7 January 2021

Hemodynamic response to pharmacological treatment of portal hypertension and long-term prognosis of cirrhosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2995267-0

7 January 2021

10.1016/S0399-8320(04)95267-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15150524%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

1 reference